Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Removing large brain artery clot, chased with clot-buster shot may improve stroke outcomes
Categories: Scientific Conferences & Meetings, Stroke News & Brain Health
|
Published: February 07, 2025

Removing large brain artery clot, chased with clot-buster shot may improve stroke outcomes

American Stroke Association International Stroke Conference – Late-Breaking Science Presentation - LB 38
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Clot in brain illustration

A clot within a blood vessel interrupting blood flow to the brain.

About Stroke | Stroke treatments

copyright American Heart Association

Download (517.4 kB)
Clot in brain illustration

Clot in brain illustration

A clot within a blood vessel interrupting blood flow to the brain.

About Stroke | Stroke treatments

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (517.4 kB) File Permalink

Clot busted with tPA illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association

Download (558.5 kB)
Clot busted with tPA illustration

Clot busted with tPA illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (558.5 kB) File Permalink

Brain illustration

The brain has about 100 billion cells called neurons. It’s made up of distinct parts, that developed though human evolution.

copyright American Heart Association

Download (426.1 kB)
Brain illustration

Brain illustration

The brain has about 100 billion cells called neurons. It’s made up of distinct parts, that developed though human evolution.

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (426.1 kB) File Permalink

Xiaochuan Huo, M.D., Ph.D.

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China.

copyright Beijing Anzhen Hospital

Download (96.6 kB)
Xiaochuan Huo, M.D., Ph.D.

Xiaochuan Huo, M.D., Ph.D.

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China.

copyright Beijing Anzhen Hospital


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (96.6 kB) File Permalink

ISC Logo

copyright American Stroke Association

Download (62.9 kB)
ISC Logo

ISC Logo

copyright American Stroke Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (62.9 kB) File Permalink
  • Clot in brain illustration
  • Clot busted with tPA illustration
  • Brain illustration
  • Xiaochuan Huo, M.D., Ph.D.
  • ISC Logo

Related Video

Previous Slide Next Slide

Ischemic Stroke with tPA animation

A computer generated graphic of a clot in the brain and the clot-busting drug, tissue plasminogen activator (tPA), working to dissolve the clot and improve blood flow to the part of the brain being deprived. 

About Stroke | Stroke treatments

copyright American Stroke Association

Please do not remove copyright from animation.

 

Download (103.7 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Ischemic Stroke with tPA animation

A computer generated graphic of a clot in the brain and the clot-busting drug, tissue plasminogen activator (tPA), working to dissolve the clot and improve blood flow to the part of the brain being deprived. 

About Stroke | Stroke treatments

copyright American Stroke Association

Please do not remove copyright from animation.

 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (103.7 MB) File Permalink

Dr. Huo ISC25 LB38 adding clot-busting injection

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (119.1 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Huo ISC25 LB38 adding clot-busting injection

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (119.1 MB) File Permalink

Dr. Huo ISC25 LB38 ANGEL-TNK trial design-results

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (147.2 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Huo ISC25 LB38 ANGEL-TNK trial design-results

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (147.2 MB) File Permalink

Dr. Huo ISC25 LB38 defines success in ANGEL-TNK trial

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (108.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Huo ISC25 LB38 defines success in ANGEL-TNK trial

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (108.4 MB) File Permalink

Dr. Huo ISC25 LB38 patient quality of life

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (109.6 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Huo ISC25 LB38 patient quality of life

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (109.6 MB) File Permalink

Dr. Huo ISC25 LB38 limitations and outcomes

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (170.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Huo ISC25 LB38 limitations and outcomes

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (170.4 MB) File Permalink

Dr. Huo ISC25 LB38 next steps

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (106.5 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Huo ISC25 LB38 next steps

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (106.5 MB) File Permalink
  • Ischemic Stroke with tPA animation
  • Dr. Huo ISC25 LB38 adding clot-busting injection
  • Dr. Huo ISC25 LB38 ANGEL-TNK trial design-results
  • Dr. Huo ISC25 LB38 defines success in ANGEL-TNK trial
  • Dr. Huo ISC25 LB38 patient quality of life
  • Dr. Huo ISC25 LB38 limitations and outcomes
  • Dr. Huo ISC25 LB38 next steps
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED